PHASE Scientific International Limited
Daniel Marshak is a seasoned professional with extensive experience in technical and business consulting within the therapeutics, diagnostics, and medical device sectors. Currently serving as Principal Consultant at Consulting & Advisory since September 2014, Marshak is also a Member of the Board of Directors at Tecan, RareCyte, Inc., and Phase Scientific International Limited, among others. Recent roles include Strategic Advisor and Chief Technology Officer at InVivo Therapeutics, as well as serving on the boards of Elevian, Inc. and LifeVault Bio. Educational credentials include a Ph.D. in Biochemistry from The Rockefeller University and a B.A. in Biochemistry from Harvard University.
This person is not in any offices
PHASE Scientific International Limited
Phase Scientific is a biotech firm that creates diagnostic and data tools to help healthcare providers and patients. They provide tools for cancer, oncology, nipt, molecular diagnostics, NGS, dd PCR, point of care, liquid-phase extraction, sample preparation, purification, enrichment, size selection, cell-free DNA, cfDNA extraction, RNA extraction,viral RNA extraction, DNA methylation, library preparation, and liquid biopsy.